Shenghua Piao
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Millettia speciosa Champ., a Plant with Potential for Development: A Comprehensive Review of Botany, Phytochemistry, Health Benefits, and Applications.
Journal: Foods (Basel, Switzerland)
Published: May 08, 2026
An analysis of the intestinal microbiome combined with metabolomics to explore the mechanism of how Pangxiejiao tea improves metabolic disorders in HFFD-treated rats.
Journal: Frontiers in nutrition
Published: June 25, 2025
Prognosis and outcome of latent autoimmune diabetes in adults: T1DM or T2DM?
Journal: Diabetology & metabolic syndrome
Published: August 09, 2024
Fufang Zhenzhu Tiaozhi (FTZ) suppression of macrophage pyroptosis: Key to stabilizing rupture-prone plaques.
Journal: Journal of ethnopharmacology
Published: November 09, 2023
Association between triglyceride-glucose index and bone mineral density in US adults: a cross sectional study.
Journal: Journal of orthopaedic surgery and research
Published: August 08, 2023
Application of machine learning in Chinese medicine differentiation of dampness-heat pattern in patients with type 2 diabetes mellitus.
Journal: Heliyon
Published: November 17, 2022
Gut microbiota is a potential goalkeeper of dyslipidemia.
Journal: Frontiers in endocrinology
Published: May 23, 2022
Long-Term Effect of Zhenzhu Tiaozhi Capsule (FTZ) on Hyperlipidemia: 2-Year Results from a Retrospective Study Using Electronic Medical Records.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: July 01, 2021
Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling.
Journal: Hepatology (Baltimore, Md.)
Published: June 14, 2021
FTZ Ameliorates Diabetic Cardiomyopathy by Inhibiting Inflammation and Cardiac Fibrosis in the Streptozotocin-Induced Model.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: June 13, 2021
The Efficacy and Safety of Chinese Medicine Fufang Zhenzhu Tiaozhi Capsule (FTZ) in the Treatment of Diabetic Coronary Heart Disease: Study Protocol for Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: March 03, 2021
Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling.
Journal: Journal of hepatology
Published: September 09, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026